{
    "ticker": "BCTX",
    "name": "BriaCell Therapeutics Corp.",
    "description": "BriaCell Therapeutics Corp. is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer. Founded in 2008, the company focuses on harnessing the power of the immune system to combat cancer, particularly through its lead product candidate, Bria-IMT, which is designed to treat advanced breast cancer. BriaCell's proprietary technology platform enables the creation of personalized immunotherapies that can stimulate the immune system to enhance its ability to recognize and attack tumor cells. The company's ongoing clinical trials aim to evaluate the safety and efficacy of Bria-IMT in combination with other treatments, such as checkpoint inhibitors. With a strong commitment to advancing cancer care, BriaCell collaborates with leading research institutions and partners to further its mission. The company\u2019s innovative approach positions it at the forefront of the rapidly evolving field of immuno-oncology, and it seeks to provide hope to patients battling cancer through its promising therapies.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Vancouver, British Columbia, Canada",
    "founded": "2008",
    "website": "https://briacell.com",
    "ceo": "Dr. Bill Williams",
    "social_media": {
        "twitter": "https://twitter.com/BriaCell",
        "linkedin": "https://www.linkedin.com/company/briacell-therapeutics-corp/"
    },
    "investor_relations": "https://briacell.com/investors",
    "key_executives": [
        {
            "name": "Dr. Bill Williams",
            "position": "CEO"
        },
        {
            "name": "Dr. Jennifer C. L. McLachlan",
            "position": "Chief Scientific Officer"
        }
    ],
    "product_categories": [
        {
            "category": "Immunotherapy",
            "products": [
                "Bria-IMT"
            ]
        }
    ],
    "seo": {
        "meta_title": "BriaCell Therapeutics Corp. | Immunotherapies for Cancer",
        "meta_description": "Explore BriaCell Therapeutics Corp., a leading biotech company focused on developing innovative immunotherapies for cancer treatment. Learn about our research and clinical trials.",
        "keywords": [
            "BriaCell",
            "Immunotherapy",
            "Cancer Treatment",
            "Biotechnology",
            "Bria-IMT"
        ]
    },
    "faq": [
        {
            "question": "What is BriaCell known for?",
            "answer": "BriaCell is known for developing innovative immunotherapies for cancer, particularly advanced breast cancer."
        },
        {
            "question": "Who is the CEO of BriaCell?",
            "answer": "Dr. Bill Williams is the CEO of BriaCell Therapeutics Corp."
        },
        {
            "question": "Where is BriaCell headquartered?",
            "answer": "BriaCell is headquartered in Vancouver, British Columbia, Canada."
        },
        {
            "question": "What is Bria-IMT?",
            "answer": "Bria-IMT is BriaCell's lead product candidate designed to treat advanced breast cancer through immunotherapy."
        },
        {
            "question": "When was BriaCell founded?",
            "answer": "BriaCell was founded in 2008."
        }
    ],
    "competitors": [
        "NK",
        "IMMP",
        "CRMD",
        "CLDX"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "JNJ",
        "PFE"
    ]
}